Emami Ltd Q2 FY2026 Concall Summary & Transcript Notes

Source transcript PDF: https://www.stockscans.in/document/g2ytwzfx0ucczfldt8pghq9w.pdf

# 1. Financial Performance

## A. Key Figures
   *   **Consolidated Revenue:** **₹799 Cr** (-10% YoY)
   *   **EBITDA:** **₹179 Cr** (-29% YoY)
   *   **PAT:** **₹148 Cr** (-30% YoY)
   *   **Gross Margin:** 71% (stable)
   *   **Interim Dividend:** **400%** (₹4/share) for FY26

## B. Revenue Decline
   *   **Tough Base Effect:** Revenue decline driven by **15% drop in domestic business**, reflecting a challenging YoY comparison from last year’s record Q2 in talc and prickly heat powder categories.

## C. Margin Stability
   *   **Margin Recovery Expected:** Gross margin held firm at 71% on cost discipline; EBITDA and net margin seen rebounding strongly in Q3 as Q2 operating deleverage unwinds.

## D. Profit Drop
   *   **Profit Pressure Transient:** Double-digit EBITDA and PAT declines attributed to temporary top-line softness, not structural margin erosion.

## E. Dividend Payout
   *   **Sustained Shareholder Returns:** Board maintained capital return discipline with a 400% interim dividend, signaling confidence in long-term cash flow resilience.

---

# 2. Volume & Pricing Trends

## A. Key Figures
   *   **Domestic Volume:** **~16% decline** (QoQ, one-off)
   *   **Grammage Increase:** **~90% of portfolio** impacted · **20% of portfolio** with higher grammage/ML (sachets)
   *   **MRP Reduction:** **INR 250 Cr** total reduction in domestic portfolio

## B. Volume Recovery
   *   **Temporary Volume Dip:** Domestic volumes down sharply on a one-off basis, with management expecting recovery in H2 excluding lost summer portfolio.

## C. Grammage Increases
   *   **Pricing Strategy Shift:** Grammage increases deployed across vast majority of portfolio as GST-driven alternative to price hikes, concentrated in small SKUs and sachets.
   *   **Minimal Volume Impact:** Higher sachet weights unlikely to affect unit sales due to single-use nature of key brands like Navratna.

## D. MRP Reductions
   *   **Consumer Relief, Delayed Impact:** Significant MRP cuts rolled out, but full benefit awaits inventory turnover; mixed stock availability currently clouds consumer response.

## E. Rural Demand
   *   **Rural Momentum:** Positive demand trends firming across categories, led by strong rural shampoo growth via Kesh King sachets.

---

# 3. Channel & Distribution

## A. Key Figures
   *   **International Business Growth:** **8%** (primary sales)
   *   **E-commerce Contribution (Quick Commerce):** **14%** of e-commerce
   *   **Domestic Consumer Business in Quick Commerce:** **~11%** each
   *   **Nepal International Growth:** **>100%** despite regional disturbances
   *   **SAARC Markets Growth:** **>22%**, led by Bangladesh
   *   **GCC & MENA Markets:** Flat (mixed regional performance)

## B. Modern Trade
   *   **Strategic Growth Recovery:** Portfolio shows strong rebound with **quarter-on-quarter improvement**, driven by low base effects and **on-ground execution momentum**.
   *   **Channel Prioritization:** Distribution strategy remains focused on modern trade, e-commerce, and quick commerce, reflecting structural shifts in consumer behavior.
   *   **Traditional Channel Strength:** Maintains robust presence in traditional retail with active investment in availability and distribution, tracking with category growth.

## C. Quick Commerce
   *   **High-Growth Channel:** Quick commerce, D2C sites, and marketplaces are key growth drivers, though **GST-related disruptions** temporarily constrained inventory at a major marketplace.
   *   **E-commerce Mix:** Quick commerce now represents a **significant 14%** of e-commerce sales, with domestic consumers forming a core part of the segment.

## D. International Channels
   *   **Resilient Global Performance:** International business delivered **modest but stable growth** amid macro and geopolitical headwinds, supported by localized innovation and portfolio relevance.
   *   **Outperformance in SAARC:** Region grew **over 22%**, with Bangladesh leading and Nepal achieving **triple-digit expansion** despite adverse conditions.
   *   **Regional Divergence:** GCC and MENA remained flat due to challenges in Egypt and Bahrain, though other markets in the region showed positive traction.
   *   **Pipeline-Driven Outlook:** Upcoming **new product developments (NPDs)** expected to strengthen international portfolio and support future growth.

---

# 4. Brand & Product Performance

## A. Key Figures
   *   **Medico Business Growth:** **8%** QoQ increase

## B. Kesh King Relaunch
   *   **Strategic Rebranding:** Kesh King relaunched as Kesh King Gold with a **"Ayurveda plus science"** positioning to counter D2C competition and align with shifting consumer preference for efficacy-driven, clinically backed formulations.
   *   **Science-Backed Reformulation:** Product enhanced with **Gro Biotin** and **plant-based Omega 369**, supported by 9–10 months of research and fully clinically proven claims across all Zandu products.
   *   **Launch Execution:** Despite GST-related delays, new formulation launched last month and is **well received in early market feedback**, with a major advertising campaign set to amplify reach.

## C. Smart & Handsome
   *   **Brand Expansion:** Rebranded from Fair and Handsome to position as a **complete men’s grooming platform**, with 12 new products introduced and initial rollout on one e-commerce platform.
   *   **Limited Rollout, High Optimism:** Currently in test marketing phase with **no wide rollout on other e-com or modern trade**, but internal sentiment is very positive; expected to operate in distinct segments without cannibalizing TMC.

## D. New Product & Communication Strategy
   *   **Growth Enablers:** Performance driven by **new brand communications** and a scaled **influencer flywheel**, contributing to strong momentum in focused categories.
   *   **Category Strength:** **Cough syrups, honey**, and the **D2C platform Zandu Care** delivered solid growth despite headwinds from GST reductions, underscoring resilience in key segments.

---

# 5. Input Cost & Demand Risks

## A. Key Figures
   *   **GST Impact:** **88%** of core domestic portfolio benefited · **93%** of portfolio now under 5% GST rate

## B. GST Disruption
   *   **Structural Benefit:** GST reform is **materially positive** for Emami, with nearly all core products now in the 5% tax bracket, enhancing affordability and competitive positioning.
   *   **Consumer-First Response:** Full GST benefit passed to consumers, reducing domestic MRP by **~₹260 Cr**, reinforcing value leadership and expected to stimulate demand in balms and oils.
   *   **Near-Term Disruption:** Temporary trade and consumer deferral caused **Q2 sales moderation**, but recovery is underway with strong rebound in **October and early November**, including in affected categories.
   *   **Confidence in Recovery:** Management expects **full volume recovery in Q3**, supported by delayed shipment clearance and restocking momentum.

## C. Summer Losses
   *   **Seasonal Headwind:** Summer portfolio underperformed with **irreversible 4–5% loss** in Q2 due to missed winter product loading, pressuring near-term volumes.

## D. Consumer Elasticity
   *   **Demand Shift:** Facing structural decline in face cream category, prompting **strategic diversification** into new segments to offset volume softness and sustain growth trajectory.
   *   **Cautious Pricing Stance:** Demand elasticity post-GST remains uncertain; any future **price adjustments or rollbacks** will be data-driven and contingent on observed consumer response over coming quarters.

---

# 6. Guidance & Outlook
  
## A. Key Figures
   *   **H2 Growth Outlook:** **Double-digit growth** expected in second half · **Highest sequential growth in 6 quarters** achieved  
   *   **Sales Outlook FY27:** **Significantly better than FY26** anticipated

## B. H2 Recovery
   *   **Strong Seasonal Rebound:** H2 off to a robust start with healthy trade sentiment and exceptional winter loading recovery across key regions, driving better-than-expected performance.  
   *   **Pipeline Normalization:** GST-related trade pipeline expected to fully recover in Q3, supporting strong H2 volume momentum.  
   *   **Margin Tailwinds:** Input cost stability positions the company for margin recovery and expansion in the second half.  
   *   **Category Scaling:** Management bullish on current quarter, actively scaling high-potential segments including the **Chyawanprash range**.

## C. Winter Demand
   *   **Early & Favorable Winter:** Winter onset in North India ~2 weeks earlier than usual, enabling early sales capture amid strong trade buoyancy.  
   *   **Extended Seasonality:** Company well-prepared to leverage winter demand not only in Q3 but also into Q4, as recent trends show prolonged winter cycles.  
   *   **Growth Determinant:** Full-year growth hinges on winter performance—potential for double-digit expansion if current momentum sustains.

## D. FY27 Expectations
   *   **Profitable Growth Trajectory:** FY27 expected to deliver robust and profitable growth, underpinned by favorable seasonality, GST normalization, organized channel expansion, and cost leadership.  
   *   **Structural Growth Drivers:** Lower base in FY26 and GST rate cut expected to boost consumer demand and drive share gains from unorganized players.

## E. Double-Digit Growth
   *   **H2 Acceleration Confirmed:** Business projected to grow at strong double-digit pace in second half, outpacing first half, fueled by increased brand investments in **Brillare and TMC**.  
   *   **Q3 Confidence with Caution:** Management confident in double-digit Q3 growth if winter trends hold, though full impact remains to be seen.